EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Hypertensive Effects of Aldosterone

Natalia Ekman iD, Ashley B Grossman iD, Anna Nieckarz iD, Łukasz Jędrzejewski, Jacek Wolf, Dorota Dworakowska iD

International Journal of Molecular Sciences · 10.01.2025 · 26 (2) · 540

DOI: 10.3390/ijms26020540 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.01.2025. Verfasst von Natalia Ekman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hypertension and Diabetology, Medical University of Gdańsk, 80-214 Gdańsk, Poland. Hauptthemen laut MEDLINE: Aldosterone. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aldosterone, the primary adrenal mineralocorticoid hormone, as an integral part of the renin–angiotensin–aldosterone system (RAAS), is crucial in blood pressure regulation and maintaining sodium and potassium levels. It interacts with the mineralocorticoid receptor (MR) expressed in the kidney and promotes sodium and water reabsorption, thereby increasing blood pressure. However, MRs are additionally expressed in other cells, such as cardiomyocytes, the endothelium, neurons, or brown adipose tissue cells. Therefore, aldosterone (especially aldosterone excess) may have other major impacts besides simply regulating blood pressure and circulating ion balance. Recent studies have reported a non-hypertensive impact on the cardiovascular, immune, and metabolic systems, a pro-oxidant effect, and a pro-fibrotic effect. In this review, we emphasise the non-hypertension-related effects of aldosterone, including advances in our understanding of the cellular mechanisms by which aldosterone mediates its cellular effects. We also summarise potential clinical complications related to both the hypertensive and non-hypertensive effects of aldosterone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AldosteroneHumansAnimalsRenin-Angiotensin SystemHypertensionBlood PressureReceptors, Mineralocorticoid

Stichwörter der Autor:innen

aldosteronecardiovascular remodellingobstructive sleep apnoeaprimary aldosteronismsubclinical atherosclerosis markersthe renin–angiotensin–aldosterone system (RAAS)

Substanzen

AldosteroneReceptors, Mineralocorticoid

Autor:innen und Institutionen

  • Department of Hypertension and Diabetology, Medical University of Gdańsk, 80-214 Gdańsk, Poland.
  • Centre for Endocrinology, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 4NS, UK.

ORCID-Profile: Natalia Ekman, Ashley B Grossman, Anna Nieckarz, Dorota Dworakowska

Zitieren

APA

Ekman, N., Grossman, A. B., Nieckarz, A., Jędrzejewski, Ł., Wolf, J., & Dworakowska, D. (2025). Non-Hypertensive Effects of Aldosterone. International Journal of Molecular Sciences, 26(2), 540. https://doi.org/10.3390/ijms26020540

Vancouver

Ekman N, Grossman AB, Nieckarz A, Jędrzejewski Ł, Wolf J, Dworakowska D. Non-Hypertensive Effects of Aldosterone. International Journal of Molecular Sciences. 2025;26(2):540. doi:10.3390/ijms26020540

BibTeX
@article{Ekman2025,
  author = {Ekman, Natalia and Grossman, Ashley B and Nieckarz, Anna and Jędrzejewski, Łukasz and Wolf, Jacek and Dworakowska, Dorota},
  title = {Non-Hypertensive Effects of Aldosterone},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {2},
  pages = {540},
  doi = {10.3390/ijms26020540}
}
Kostenlos starten →